Nuvectis Pharma, Inc. (NVCT)
23.87
+0.31
(+1.32%)
USD |
NASDAQ |
Aug 24, 16:00
23.86
-0.01
(-0.04%)
After-Hours: 20:00
Nuvectis Pharma 1 Year Total Returns (Daily) : 247.5% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 247.5% |
| August 21, 2026 | 271.6% |
| August 20, 2026 | 257.0% |
| August 19, 2026 | 280.0% |
| August 18, 2026 | 224.2% |
| August 17, 2026 | 196.7% |
| August 14, 2026 | 194.9% |
| August 13, 2026 | 201.9% |
| August 12, 2026 | 186.5% |
| August 11, 2026 | 216.6% |
| August 10, 2026 | 214.6% |
| August 07, 2026 | 207.1% |
| August 06, 2026 | 191.5% |
| August 05, 2026 | 179.1% |
| August 04, 2026 | 175.7% |
| August 03, 2026 | 217.6% |
| July 31, 2026 | 209.2% |
| July 30, 2026 | 201.5% |
| July 29, 2026 | 173.7% |
| July 28, 2026 | 160.8% |
| July 27, 2026 | 151.2% |
| July 24, 2026 | 149.8% |
| July 23, 2026 | 156.4% |
| July 22, 2026 | 138.7% |
| July 21, 2026 | 139.1% |
| Date | Value |
|---|---|
| July 20, 2026 | 131.2% |
| July 17, 2026 | 140.8% |
| July 16, 2026 | 127.7% |
| July 15, 2026 | 136.6% |
| July 14, 2026 | 122.5% |
| July 13, 2026 | 134.0% |
| July 10, 2026 | 124.1% |
| July 09, 2026 | 135.0% |
| July 08, 2026 | 147.4% |
| July 07, 2026 | 144.6% |
| July 06, 2026 | 160.3% |
| July 02, 2026 | 160.2% |
| July 01, 2026 | 167.0% |
| June 30, 2026 | 146.2% |
| June 29, 2026 | 277.9% |
| June 26, 2026 | 252.7% |
| June 25, 2026 | 260.1% |
| June 24, 2026 | 206.8% |
| June 23, 2026 | 120.5% |
| June 22, 2026 | 103.3% |
| June 18, 2026 | 71.68% |
| June 17, 2026 | 55.24% |
| June 16, 2026 | 38.19% |
| June 15, 2026 | 32.58% |
| June 12, 2026 | 21.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Decoy Therapeutics, Inc. | -95.51% |
| Unicycive Therapeutics, Inc. | 27.14% |
| ACADIA Pharmaceuticals, Inc. | 15.19% |
| Alnylam Pharmaceuticals, Inc. | -48.06% |
| Anika Therapeutics, Inc. | 121.1% |